Shield Therapeutics (LON:STX) Stock Passes Below Fifty Day Moving Average of $10.10

Shield Therapeutics plc (LON:STXGet Rating)’s stock price crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 10.10 ($0.12) and traded as low as GBX 7.05 ($0.09). Shield Therapeutics shares last traded at GBX 7.25 ($0.09), with a volume of 1,437,900 shares trading hands.

Shield Therapeutics Stock Performance

The firm has a market cap of £15.67 million and a P/E ratio of -0.83. The company has a debt-to-equity ratio of 0.38, a quick ratio of 4.11 and a current ratio of 5.11. The company’s 50 day moving average is GBX 10.10 and its 200 day moving average is GBX 18.50.

About Shield Therapeutics

(Get Rating)

Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of clinical stage pharmaceuticals to treat unmet medical needs. The company's lead product is Accrufer/Feraccru, a non-salt based oral therapy for the treatment of iron deficiency with or without anemia in adults.

Featured Articles

Want More Great Investing Ideas?

Receive News & Ratings for Shield Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shield Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.